BioInvent International AB (publ) (STO:BINV)

STO:BINV Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Feb 21, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	1,553	1,248	2,082	2,701	1,753	613
Market Cap Growth	189.27%	-40.08%	-22.92%	54.06%	185.96%	-8.10%
Enterprise Value	620	115	882	1,475	1,122	446
Last Close Price	23.60	18.96	32.05	46.20	45.90	30.01
Forward PE	-	-	-	-	3.29	-
PS Ratio	40.22	17.46	6.38	139.36	11.90	6.54
PB Ratio	1.55	0.95	1.30	1.98	2.36	3.62
P/TBV Ratio	3.17	0.95	1.30	1.98	2.36	3.62
EV/Sales Ratio	16.04	1.61	2.71	76.08	7.62	4.76
Debt / Equity Ratio	0.02	0.02	0.02	0.02	0.02	0.09
Asset Turnover	0.03	0.05	0.21	0.02	0.29	0.54
Quick Ratio	13.16	14.60	12.11	18.64	14.34	3.97
Current Ratio	13.29	14.93	12.41	18.98	14.45	4.09
Return on Equity (ROE)	-34.01%	-22.66%	-2.86%	-26.39%	-16.72%	-107.86%
Return on Assets (ROA)	-22.21%	-14.88%	-2.00%	-15.45%	-9.11%	-49.42%
Return on Capital (ROIC)	-23.33%	-15.62%	-2.08%	-16.17%	-9.97%	-62.82%
Earnings Yield	-26.38%	-26.47%	-2.04%	-10.31%	-4.35%	-22.61%
FCF Yield	-23.60%	-28.45%	-2.57%	-9.59%	-3.95%	-21.08%
Buyback Yield / Dilution	-0.96%	-6.90%	-13.59%	-88.61%	-58.29%	-33.60%
Total Shareholder Return	-0.96%	-6.90%	-13.59%	-88.61%	-58.29%	-33.60%

Source: S&P Capital IQ. Standard template. Financial Sources.